本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pasithea Therapeutics Corp.

0.8700
+0.03904.69%
盤後0.87000.00000.00%18:31 EDT
成交量:103.61萬
成交額:88.58萬
市值:568.05萬
市盈率:-0.07
高:0.9000
開:0.8850
低:0.8223
收:0.8310
資料載入中...
2022/12/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report